Stockreport

BeiGene Highlights Innovative Hematology Portfolio Across B-cell Malignancies at ASH 2024

BeiGene, Ltd. - American Depositary Shares  (BGNE) 
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report
PDF Five-year results of Phase 3 SEQUOIA study demonstrate durable benefits of BRUKINSA in patients with CLLTwo oral presentations showcase promising safety and efficacy dat [Read more]